Immunome
IMNM
$13.83
Share price
-3.96%
Change (1 day)
143.92%
Change (1 year)
Categories
Immunome (IMNM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $28.65 M
According to Immunome's latest financial reports the company's total liabilities are $28.65 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Immunome - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $7.39 M | -24.1% |
| 2021-12-31 | $9.74 M | 206.29% |
| 2020-12-31 | $3.18 M | -92.18% |
| 2019-12-31 | $40.69 M | 37.22% |
| 2018-12-31 | $29.65 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -2.58% | 🇺🇸 USA |